Pfizer climbs after leaning on upside trend line - Analysis - 13-02-2018

Pfizer's stock (PFE) rose in the intraday levels, scoring a fresh profit of 1.46% in the last session, or 0.50 points, after leaning on the medium-term upward trend line as shown in the attached chart, while the RSI reached extremely oversold levels, countered with negative pressure from the 50-day SMA. 

Therefore we expect more gains for the stock, especially if it settled back above 34.63, targeting the resistance of 37.39.